top of page
arrow-bg-right.gif

D3 Valuation Accelerator

D3 (Due Diligence Diagnostic) is an AI-enabled investment intelligence platform helping capital investment firms increase the success and valuation of its portfolio companies. ​

 

The D3 ​platform quickly diagnoses barriers to growth and suggests meaningful operational changes to...

  • Increase portfolio value
 
  • Ensure accountability
  • Reduce investment risk   

Welcome to Exit Science. Our D3 Valuation Accelerator Platform will launch on August 3, 2026. To learn more or to schedule a demo, please contact us below.

WHAT

What we will do together. Soon.

Make better investment portfolio decisions with always-on, reliable, and focused AI-enabled and people-driven data.

In an extremely competitive funding environment, your edge is picking the best companies to provide meaningful returns on your investments. 
What happens when the performance promises the portfolio company made in their pitch become performance issues in their updates?
 
​Your board and advisors need to know the company is aligned with their expectations for an optimal outcome, and the executive team is hitting the growth KPIs they promised.
​​

D3 gives your portfolio AI-enabled, people-driven investment risk reduction strategies to mitigate often unseen threats and provide meaningful, measurable, and accountable value growth plans.  

01

D3 Business Scan
You and your portfolio team's CEO take a 7-minute survey to identify high-level value growth barriers and illustrate the gap between current and optimal company value.

02

D3 Diagnostic
Knowing the valuation gap and its broad causes is a start. Our Diagnostic provides a deep dive into almost every aspect of the company's operation. The output of the Diagnostic is a thorough analysis of 7 key Business Signals impacting value. 

Each Signal has specific performance scores attached and corelates to its impact on valuation. Most importantly, the Signals include specific suggestions to improve performance in each area. Those signals are color-coded for performance triage -
Red for Urgent; Yellow for Emergent; and Green for Meeting or Exceeding.

At the Diagnostic stage, the system inputs are static. The Diagnostic Report simply identifies issues as a snapshot, not a movie, while providing reasonable suggestions to mitigate, measure, and report on improvements for each Signal. 

\At 

03

D3 Performance Measurement and Monitoring
Poor execution is the death knell for most unsuccessful companies, and investments. 
For portfolio managers, monitoring performance and suggesting operational improvements has been an exercise in looking back instead of forward. 

We fix that rearview planning. As D3 moves from diagnosing the issues into measuring and monitoring the solutions agreed by the Board and Executives of the portfolio company the secure integration with the company's internal systems becomes a priority.

Having access to "living documents" in the system allows D
to provide an up-to-date dashboard on the critical business signals for the portfolio manager and the executive team. The system generates monthly, quarterly, and annual reports based on the most current data from sales revenue to product development, allowing your finance team to focus on the business and not the reports.  \At 

Business Meeting
Blurred Business People
Green Arrow Icon

Get in touch.

Ready to hear how Exit Science can help your portfolio achieve its valuation goals?

Exit Science logo

© 2024 Copyright Exit Science. Designed by Haylo Branding + Marketing

bottom of page